Explore daily insights on
Gilead FY EPS flips to -$0.82 from +$8.65 in one week — 17 analyst cuts, zero upgrades
- Gilead Sciences' full-year EPS consensus swung from a profit of $8.65 to a loss of -$0.82 in just seven days, driven by a massive one-time charge that crushed the current-quarter estimate
- The current-quarter EPS estimate collapsed to -$6.90 from +$1.94 in 7 days (14 cuts, 0 upgrades); 17 analysts cut the full-year figure with zero upgrades
- This is the sharpest single-week consensus reversal in the dataset — a swing of more than $9.47 per share in FY EPS in one week
Supporting datasets
Supporting queries
To surface this insight, Baselight ran 3 queries across its structured data. Each one is reproducible — open it, read the SQL, and rerun it yourself.
Conclusion
FY EPS consensus: current -$0.82 vs 7d ago +$8.65 (swing of -$9.47); current-Q EPS: -$6.90 vs +$1.94 7d ago; eps_revisions: 0 up / 17 down (FY), 0 up / 14 down (current Q); stock closed $133.05 on May 13, 52w high $157.29.